-
The FDA has approved the first fixed-dose combination product for the treatment of type 2 diabetes and hypercholesterolemia. This tablet combines a dipeptidyl peptidase-4 inhibitor (sitagliptin) and a HMG-CoA reductase inhibitor (simvastatin).
-
-
Since there is a lack of prospective data on the frequency of which constrictive pericarditis (CP) develops after acute pericarditis (AP), this group of investigators from Torino, Italy, conducted such a study.
-
-
Clopidogrel therapy is indicated for many patients with cardiovascular disease, particularly those who have had percutaneous coronary intervention (PCI).
-
Patients who have had percutaneous coronary intervention (PCI) with either bare metal stents (BMS) or drug-eluting stents (DES) require dual antiplatelet therapy until the stent struts are endothelialized.
-
-
The management of chronic heart failure patients would benefit from an accurate noninvasive way to estimate left atrial pressure (LAP).
-
Medication poisonings in children; rosuvastatin vs atorvastatin for atherosclerosis; saw palmetto for prostate symptoms; using atypical antipsychotics for off-label indications in adults; and FDA actions.
-
This paper describes the mortality and economic costs of infections associated with pacemakers and implantable defibrillators (ICDs) in Medicare recipients.
